Actavis Management Discusses Q1 2014 Results – Earnings Call Transcript

Actavis Management Discusses Q1 2014 Results - Earnings Call Transcript Finally, we announced that the district court ruled in our favor and upheld t...


Actavis Management Discusses Q1 2014 Results – Earnings Call Transcript
Finally, we announced that the district court ruled in our favor and upheld the validity of our patent on Lo Loestrin Fe. In our North American Brands business, we announced the approval of Metronidazole 1.3% for the treatment of vaginal fungal infections.
Read more on Seeking Alpha

Leave a Reply